A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.

GPR37, also known as parkin-associated endothelin-like receptor (Pael-R), is an orphan G protein-coupled receptor (GPCR). It has been reported that GPCRs play vital roles in the development and progression of cancer. To investigate the potential roles of GPR37 in hepatocellular carcinoma (HCC), expression of GPR37 was examined in human HCC samples. Immunohistochemistry and Western blot analyses were performed for GPR37 in 57 hepatocellular carcinoma samples. GPR37 expression was low in hepatocellular carcinoma as compared with the adjacent non-tumorous tissues. Clinicopathological analysis showed that GPR37 expression was significantly correlated with histological grade and the level of alpha fetal protein (AFP) (P = 0.000 and 0.002, respectively). The Kaplan-Meier survival curves revealed that decreasing GPR37 expression was associated with poor prognosis in HCC patients, while in vitro, following the release from serum starvation of HuH7 HCC cell, the expression of GPR37 was downregulated. In addition, the transient GPR37 knockdown by siRNA in HuH7 cells significantly decreased the apoptosis of hepatoma cells with activation of the phosphatidylinositol 3-kinase-Akt signaling pathway. Our data suggest that GPR37 may play an important role in the pathogenesis of hepatocellular carcinoma by affecting the proliferation of H CC cells, and it could be a novel potential molecular therapy target for HCC.

[1]  Yan Ding,et al.  Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients , 2009, International journal of cancer.

[2]  N. Hattori,et al.  An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.

[3]  W. Lau,et al.  Hepatocellular carcinoma: current management and recent advances. , 2008, Hepatobiliary & pancreatic diseases international : HBPD INT.

[4]  H. Schaller,et al.  The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37 , 2006, Journal of Cell Science.

[5]  G. Viglietto,et al.  Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. , 1999, The Journal of clinical investigation.

[6]  J. Ferlay,et al.  Estimates of the worldwide mortality from 25 cancers in 1990 , 1999, International journal of cancer.

[7]  H. Hamm,et al.  Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription. , 2007, Current opinion in genetics & development.

[8]  Haiyang Xie,et al.  G Protein-Coupled Receptor 87 (GPR87) Promotes the Growth and Metastasis of CD133+ Cancer Stem-Like Cells in Hepatocellular Carcinoma , 2013, PloS one.

[9]  J. Siegfried,et al.  Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. , 2006, Cancer research.

[10]  上田 秀一.  PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib , 2006 .

[11]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[12]  Shinji Tanaka,et al.  Molecular targeted therapies in hepatocellular carcinoma. , 2012, Seminars in oncology.

[13]  R. Takahashi,et al.  Pael‐R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss , 2008, Journal of neurochemistry.

[14]  A. Dennison,et al.  Prognostic molecular markers in hepatocellular carcinoma: a systematic review. , 2007, European journal of cancer.

[15]  C. J. Chen,et al.  Correlations of chronic hepatitis B virus infection and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma. , 1994, Cancer research.

[16]  L. Mishra,et al.  Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis , 2008, Hepatology.

[17]  R. Meyer,et al.  GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions. , 2009, Biochemistry.

[18]  G. Tocchini-Valentini,et al.  Molecular cloning and chromosomal localization of the mouse Gpr37 gene encoding an orphan G-protein-coupled peptide receptor expressed in brain and testis. , 1998, Genomics.

[19]  J. Michiels,et al.  GPR30, the Non-Classical Membrane G Protein Related Estrogen Receptor, Is Overexpressed in Human Seminoma and Promotes Seminoma Cell Proliferation , 2012, PloS one.

[20]  H. Iwaasa,et al.  Anatomical and histological profiling of orphan G-protein-coupled receptor expression in gastrointestinal tract of C57BL/6J mice , 2009, Cell and Tissue Research.

[21]  A. Psyrri,et al.  Pathways and targets in hepatocellular carcinoma , 2012, Expert review of anticancer therapy.

[22]  R. Dhanasekaran,et al.  Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics , 2012, Hepatic medicine : evidence and research.

[23]  Mitsugu Sekimoto,et al.  Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  Tara L. Kieffer,et al.  Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .

[25]  Weihua Jia,et al.  Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. , 2009, Carcinogenesis.

[26]  R. Takahashi,et al.  Pael receptor, endoplasmic reticulum stress, and Parkinson’s disease , 2003, Journal of Neurology.

[27]  B. Sommer,et al.  Part I: Parkin-associated proteins and Parkinson’s disease , 2003, Neuropharmacology.

[28]  J. Cheville,et al.  p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. , 1999, The American journal of pathology.